The DOI matches its Crossref record; 69 of the 69 references it cites were found in a registry or an index.
Functional selectivity of EGF family peptide growth factors: Implications for cancer
Open accessAbstract
Breast, prostate, pancreatic, colorectal, lung, and head and neck cancers exploit deregulated signaling by ErbB family receptors and their ligands, EOF family peptide growth factors. EGF family members that stimulate the same receptor are able to stimulate divergent biological responses both in cell culture and in vivo. This is analogous to the functional selectivity exhibited by ligands for G-protein coupled receptors. Here we review this literature and propose that this functional selectivity of EGF family members is due to distinctions in the conformation of the liganded receptor and subsequent differences in the sites of receptor tyrosine phosphorylation and receptor coupling to signaling effectors. We also discuss the roles of divergent ligand activity in establishing and maintaining malignant phenotypes. Finally, we discuss the potential of mutant EGF family ligands as cancer chemotherapeutics targeted to ErbB receptors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lapatinib plus Capecitabine for HER2-Positive Advanced Breast Cancer
Geyer, C. E., Forster, J., Lindquist, D., Chan, S., Romieu, C. G., Pienkowski, T., Jagiello-Gruszfeld, A., Crown, J., Chan, A., Kaufman, B., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa064320 · Cited by 3,425
EGF–ERBB signalling: towards the systems level
Citri, A., & Yarden, Y. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1962 · Cited by 2,004
An allosteric mechanism for activation of the kinase domain of epidermal growth factor receptor
Zhang, X., Gureasko, J., Shen, K., Cole, P. A., & Kuriyan, J. (2006) · Cell · doi:10.1016/j.cell.2006.05.013 · Cited by 1,650
Crystal Structure of the Complex of Human Epidermal Growth Factor and Receptor Extracellular Domains
Ogiso, H., Ishitani, R., Nureki, O., Fukai, S., Yamanaka, M., Kim, J.-H., Saito, K., Sakamoto, A., Inoue, M., Shirouzu, M., et al. (2002) · Cell · doi:10.1016/s0092-8674(02)00963-7 · Cited by 1,227
Functional Selectivity and Classical Concepts of Quantitative Pharmacology
Urban, J. D., Clarke, W. P., von Zastrow, M., Nichols, D. E., Kobilka, B., Weinstein, H., Javitch, J. A., Roth, B. L., Christopoulos, A., Sexton, P. M., et al. (2007) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.104463 · Cited by 1,116
Levkowitz, G., Waterman, H., Ettenberg, S. A., Katz, M., Tsygankov, A. Y., Alroy, I., Lavi, S., Iwai, K., Reiss, Y., Ciechanover, A., et al. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80231-2 · Cited by 1,001
Mechanisms of Disease: understanding resistance to HER2-targeted therapy in human breast cancer
Nahta, R., Yu, D., Hung, M.-C., Hortobagyi, G. N., & Esteva, F. J. (2006) · Nature Clinical Practice Oncology · doi:10.1038/ncponc0509 · Cited by 916
An Open-and-Shut Case? Recent Insights into the Activation of EGF/ErbB Receptors
Burgess, A. W., Cho, H.-S., Eigenbrot, C., Ferguson, K. M., Garrett, T. P. J., Leahy, D. J., Lemmon, M. A., Sliwkowski, M. X., Ward, C. W., & Yokoyama, S. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00350-2 · Cited by 909
Self-citationc-Cbl/Sli-1 regulates endocytic sorting and ubiquitination of the epidermal growth factor receptor
Levkowitz, G., Waterman, H., Zamir, E., Kam, Z., Oved, S., Langdon, W. Y., Beguinot, L., Geiger, B., & Yarden, Y. (1998) · Genes & Development · doi:10.1101/gad.12.23.3663 · Cited by 865
Specificity within the EGF family/ErbB receptor family signaling network
Riese, D. J., & Stern, D. F. (1998) · BioEssays · doi:10.1002/(sici)1521-1878(199801)20:1<41::aid-bies7>3.0.co;2-v · Cited by 809
Self-citationCameron, D., Casey, M., Press, M., Lindquist, D., Pienkowski, T., Romieu, C. G., Chan, S., Jagiello-Gruszfeld, A., Kaufman, B., Crown, J., et al. (2008) · Breast Cancer Research and Treatment · doi:10.1007/s10549-007-9885-0 · Cited by 794
Garrett, T. P. J., McKern, N. M., Lou, M., Elleman, T. C., Adams, T. E., Lovrecz, G. O., Zhu, H.-J., Walker, F., Frenkel, M. J., Hoyne, P. A., et al. (2002) · Cell · doi:10.1016/s0092-8674(02)00940-6 · Cited by 783
Phosphotyrosine interactome of the ErbB‐receptor kinase family
Schulze, W. X., Deng, L., & Mann, M. (2005) · Molecular Systems Biology · doi:10.1038/msb4100012 · Cited by 753
Ritter, C. A., Perez-Torres, M., Rinehart, C., Guix, M., Dugger, T., Engelman, J. A., & Arteaga, C. L. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0701 · Cited by 497
Vassar, R., & Fuchs, E. (1991) · Genes & Development · doi:10.1101/gad.5.5.714 · Cited by 409
Autocrine, paracrine and juxtacrine signaling by EGFR ligands
Singh, A. B., & Harris, R. C. (2005) · Cellular Signalling · doi:10.1016/j.cellsig.2005.03.026 · Cited by 400
Binding specificities and affinities of egf domains for ErbB receptors
Jones, J. T., Akita, R. W., & Sliwkowski, M. X. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)00283-5 · Cited by 381
ADAMs as mediators of EGF receptor transactivation by G protein-coupled receptors
Ohtsu, H., Dempsey, P. J., & Eguchi, S. (2006) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00620.2005 · Cited by 338
Rotin, D., Margolis, B., Mohammadi, M., Daly, R. J., Daum, G., Li, N., Fischer, E. H., Burgess, W. H., Ullrich, A., & Schlessinger, J. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05087.x · Cited by 331
Dawson, J. P., Berger, M. B., Lin, C.-C., Schlessinger, J., Lemmon, M. A., & Ferguson, K. M. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.17.7734-7742.2005 · Cited by 297
Self-citationThe ErbB Receptors and their Ligands in Cancer: An Overview
Normanno, N., Bianco, C., Strizzi, L., Mancino, M., Maiello, M., Luca, A., Caponigro, F., & Salomon, D. (2005) · Current Drug Targets · doi:10.2174/1389450053765879 · Cited by 275
The Neuregulin-I/ErbB Signaling System in Development and Disease
(2007) · Advances in Anatomy Embryology and Cell Biology · doi:10.1007/978-3-540-37107-6 · Cited by 243
Transgenic expression of the human amphiregulin gene induces a psoriasis-like phenotype.
Cook, P. W., Piepkorn, M., Clegg, C. H., Plowman, G. D., DeMay, J. M., Brown, J. R., & Pittelkow, M. R. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119766 · Cited by 225
The role of EGF-related peptides in tumor growth
Normanno, N. (2001) · Frontiers in Bioscience · doi:10.2741/a635 · Cited by 216
Membrane‐anchored growth factors, the epidermal growth factor family: Beyond receptor ligands
Higashiyama, S., Iwabuki, H., Morimoto, C., Hieda, M., Inoue, H., & Matsushita, N. (2008) · Cancer Science · doi:10.1111/j.1349-7006.2007.00676.x · Cited by 215
Gee, J. M., Robertson, J. F., Gutteridge, E., Ellis, I. O., Pinder, S. E., Rubini, M., & Nicholson, R. I. (2005) · Endocrine-Related Cancer · doi:10.1677/erc.1.01005 · Cited by 209
GPCR functional selectivity has therapeutic impact
Mailman, R. B. (2007) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2007.06.002 · Cited by 208
Ishikawa, N., Daigo, Y., Takano, A., Taniwaki, M., Kato, T., Hayama, S., Murakami, H., Takeshima, Y., Inai, K., Nishimura, H., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1556 · Cited by 194
Control of ErbB signaling through metalloprotease mediated ectodomain shedding of EGF-like factors
Sanderson, M. P., Dempsey, P. J., & Dunbar, A. J. (2006) · Growth Factors · doi:10.1080/08977190600634373 · Cited by 190
Regulating the dynamics of EGF receptor signaling in space and time
Shilo, B.-Z. (2005) · Development · doi:10.1242/dev.02006 · Cited by 189
Prediction of sensitivity of advanced non-small cell lung cancers to gefitinib (Iressa, ZD1839)
Kakiuchi, S., Daigo, Y., Ishikawa, N., Furukawa, C., Tsunoda, T., Yano, S., Nakagawa, K., Tsuruo, T., Kohno, N., Fukuoka, M., et al. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh331 · Cited by 173
Sorkin, A., Mazzotti, M., Sorkina, T., Scotto, L., & Beguinot, L. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.23.13377 · Cited by 168
Willmarth, N. E., & Ethier, S. P. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m606532200 · Cited by 163
Keilhack, H., Tenev, T., Nyakatura, E., Godovac-Zimmermann, J., Nielsen, L., Seedorf, K., & Böhmer, F.-D. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.38.24839 · Cited by 160
Heregulin-dependent Activation of Phosphoinositide 3-Kinase and Akt via the ErbB2/ErbB3 Co-receptor
Hellyer, N. J., Kim, M.-S., & Koland, J. G. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m102079200 · Cited by 156
Am, D., Wang, X., King, L. E., Nanney, L., Ta, G., Sellheyer, K., Bundman, D. S., Longley, M., Rothnagel, J. A., & Da, G. (1993) · PubMed · Cited by 153
ErbB and HB-EGF Signaling in Heart Development and Function
Iwamoto, R., & Mekada, E. (2006) · Cell Structure and Function · doi:10.1247/csf.31.1 · Cited by 148
Révillion-Carette, F., Lhotellier, V., Hornez, L., Bonneterre, J. M., & Peyrat, J. P. (2007) · Annals of Oncology · doi:10.1093/annonc/mdm431 · Cited by 142
Signaling through ERBB receptors: Multiple layers of diversity and control
Warren, C. M., & Landgraf, R. (2006) · Cellular Signalling · doi:10.1016/j.cellsig.2005.12.007 · Cited by 137
Ligand Discrimination in Signaling through an ErbB4 Receptor Homodimer
Sweeney, C. A., Lai, C., Riese, D. J., Diamonti, A. J., Cantley, L. C., & Carraway, K. L. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.c901015199 · Cited by 129
Self-citationWhere next for gefitinib in patients with lung cancer?
Blackhall, F. H., Ranson, M., & Thatcher, N. (2006) · The Lancet Oncology · doi:10.1016/s1470-2045(06)70725-2 · Cited by 129
Plosker, G. L., & Keam, S. J. (2006) · Drugs · doi:10.2165/00003495-200666040-00005 · Cited by 127
Kochupurakkal, B. S., Harari, D., Segni, A. D., Maik-Rachline, G., Lyass, L., Gur, G., Kerber, G., Citri, A., Lavi, S., Eilam, R., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m413919200 · Cited by 122
Storniolo, A. M., Pegram, M. D., Overmoyer, B. A., Silverman, P., Peacock, N. W., Jones, S. F., Loftiss, J., Arya, N., Koch, K. M., Paul, E. M., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.13.5202 · Cited by 117
Eckstein, N., Servan, K., Girard, L., Cai, D., von Jonquières, G., Jaehde, U., Kassack, M. U., Gazdar, A. F., Minna, J. D., & Royer, H. D. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m706287200 · Cited by 115
Mahtouk, K., Cremer, F. W., Rème, T., Jourdan, M., Baudard, M., Moreaux, J., Requirand, G., Fiol, G., De Vos, J., Moos, M., et al. (2006) · Oncogene · doi:10.1038/sj.onc.1209699 · Cited by 105 · cited 1×
“…et al., 2001; Jones et al., 2003; Nanba & Higashiyama, 2004; Nishi & Klagsbrun, 2004; Shilo, 2005; Singh & Harris, 2005; Citri & Yarden, 2006; Edwin et al., 2006; Iwamoto & Mekada, 2006; Mahtouk et al., 2006; Ohtsu et al., 2006; Sanderson et al., 2006; Britsch, 2007; Higashiyama et al., 2008).”
Burke, C., & Stern, D. F. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.9.5371 · Cited by 104
Neuregulin isoforms exhibit distinct patterns of ErbB family receptor activation
Hobbs, S. S., Coffing, S. L., Le, A., Cameron, E. M., Williams, E. E., Andrew, M., Blommel, E. N., Hammer, R. P., Han, C. L., & Riese, D. J. (2002) · Oncogene · doi:10.1038/sj.onc.1205960 · Cited by 104
Self-citationCook, P. W., Brown, J. R., Cornell, K., & Pittelkow, M. R. (2004) · Experimental Dermatology · doi:10.1111/j.0906-6705.2004.00183.x · Cited by 98
Alterations of Gene Expression in the Development of Early Hyperplastic Precursors of Breast Cancer
Lee, S., Medina, D., Tsimelzon, A. I., Mohsin, S. K., Mao, S., Wu, Y., & Allred, D. C. (2007) · American Journal Of Pathology · doi:10.2353/ajpath.2007.061010 · Cited by 82
HER4-mediated Biological and Biochemical Properties in NIH 3T3 Cells
Cohen, B. D., Green, J. M., Foy, L., & Fell, H. P. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.9.4813 · Cited by 81
Nishi, E., & Klagsbrun, M. (2004) · Growth Factors · doi:10.1080/08977190400008448 · Cited by 79
Lemos-González, Y., Rodrı́guez-Berrocal, F. J., Cordero, O. J., Gómez, C., & de la Cadena, M. P. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603770 · Cited by 79
EGF and amphiregulin differentially regulate Cbl recruitment to endosomes and EGF receptor fate
Stern, K. A., Place, T. L., & Lill, N. L. (2008) · Biochemical Journal · doi:10.1042/bj20071505 · Cited by 78
Kaushansky, A., Gordus, A., Budnik, B., Lane, W. A. S., Rush, J., & MacBeath, G. (2008) · Chemistry and Biology · doi:10.1016/j.chembiol.2008.07.006 · Cited by 76
A Historical Perspective of the EGF Receptor and Related Systems
Edwin, F., Wiepz, G. J., Singh, R., Peet, C. R., Chaturvedi, D., Bertics, P. J., & Patel, T. B. (2006) · Humana Press eBooks · doi:10.1385/1-59745-012-x:1 · Cited by 72
Amphiregulin-EGFR signaling regulates PTHrP gene expression in breast cancer cells
Gilmore, J. L., Scott, J. A., Bouizar, Z., Robling, A. G., Pitfield, S. E., Riese, D. J., & Foley, J. (2007) · Breast Cancer Research and Treatment · doi:10.1007/s10549-007-9748-8 · Cited by 71
Self-citationStreicher, K. L., Willmarth, N. E., García, J. M., Boerner, J. L., Dewey, T. G., & Ethier, S. P. (2007) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-06-0427 · Cited by 71
Neuroglycan C, a novel member of the neuregulin family
Kinugasa, Y., Ishiguro, H., Tokita, Y., Oohira, A., Ohmoto, H., & Higashiyama, S. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.07.066 · Cited by 63
Normanno, N., & Gullick, W. J. (2006) · Endocrine Related Cancer · doi:10.1677/erc.1.01185 · Cited by 60
Nanba, D., & Higashiyama, S. (2003) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2003.10.002 · Cited by 59
Williams, E. E., Trout, L. J., Gallo, R. M., Pitfield, S. E., Bryant, I., Penington, D. J., & Riese, D. J. (2003) · Cancer Letters · doi:10.1016/s0304-3835(02)00690-0 · Cited by 48
Self-citationZrihan‐Licht, S., Deng, B., Yarden, Y., McShan, G. D., Keydar, I., & Avraham, H. K. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.7.4065 · Cited by 42
Differential effects of amphiregulin and TGF-α on the morphology of MDCK cells
Chung, E., Graves‐Deal, R., Franklin, J. L., & Coffey, R. J. (2005) · Experimental Cell Research · doi:10.1016/j.yexcr.2005.05.012 · Cited by 41
Hobbs, S. S., Cameron, E. M., Hammer, R. P., Le, A., Gallo, R. M., Blommel, E. N., Coffing, S. L., Chang, H., & Riese, D. J. (2003) · Oncogene · doi:10.1038/sj.onc.1207250 · Cited by 30
Self-citationJones, F. E., Golding, J. P., & Gassmann, M. (2003) · Cell Cycle · doi:10.4161/cc.2.6.598 · Cited by 30
Pitfield, S. E., Bryant, I., Penington, D. J., Park, G., & Riese, D. J. (2006) · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · doi:10.3727/000000006783981134 · Cited by 28
Self-citationGilmore, J. L., Gallo, R. M., & Riese, D. J. (2006) · Biochemical Journal · doi:10.1042/bj20051687 · Cited by 17
Self-citationInter-conversion of neuregulin2 full and partial agonists for ErbB4
Wilson, K. J., Mill, C. P., Cameron, E. M., Hobbs, S. S., Hammer, R. P., & Riese, D. J. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.10.004 · Cited by 17
Self-citation
Cited by
Epidermal Growth Factor Receptor Cell Proliferation Signaling Pathways
Wee, P., & Wang, Z. (2017) · Cancers · doi:10.3390/cancers9050052 · Cited by 2,027
Emerging functions of the EGFR in cancer
Sigismund, S., Avanzato, D., & Lanzetti, L. (2018) · Molecular Oncology · doi:10.1002/1878-0261.12155 · Cited by 1,469
The ErbB/HER family of protein-tyrosine kinases and cancer
Roskoski, R. (2014) · Pharmacological Research · doi:10.1016/j.phrs.2013.11.002 · Cited by 1,353
Epidermal growth factor receptor targeting in cancer: a review of trends and strategies
Yewale, C., Baradia, D., Vhora, I., Patil, S., & Misra, A. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.07.100 · Cited by 533
The EGFR Family: Not So Prototypical Receptor Tyrosine Kinases
Lemmon, M. A., Schlessinger, J., & Ferguson, K. M. (2014) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a020768 · Cited by 475
Self-citation
Metadata
- Authors
- Wilson, K. J., Gilmore, J. L., Foley, J., Lemmon, M. A., & Riese, D. J.
- Venue
- Pharmacology & Therapeutics
- Publisher
- Elsevier BV
- Published
- 2009-04
- Volume
- 122
- Issue
- 1
- Pages
- 1-8
- ISSN
- 0163-7258 (ISSN-L)
- OpenAlex
- W2075559535
- Cited by
- 285
- References
- 69
- FWCI
- 4.77
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.